Supported by

TAVI (Transcatheter aortic valve implantation)

Find all the latest content on TAVI published on this website.

TAVI, now an established, valid treatment for patients presenting with symptomatic severe aortic stenosis, has proven to be superior to medical treatment for inoperable patients whilst being a valid alternative to surgery in select, high-risk patients. This topic covers the newest devices and emerging data in TAVI as well as information on tools, devices and techniques such as vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography, understanding bleeding risks or patient selection. Use the filters below to access PCRonline resources.

Anatomy of the aortic valvar complex

View a detailed and comprehensive description of the anatomy of the aortic valvar complex as it pertains to TAVI.

View illustrated aortic valvar complex

Filtered By
TAVI

1472 results

TAVI – managing PVL and PPI risk: device vs procedure

28 Jul 2022

Watch the 2nd module in this series to review mechanisms and literature of PVL in TAVIs, and much more! With Anthony Camuglia, Kentaro Hayashida and Ganesh Manoharan

TAVI limiting the risks: Patient & Mismatch

Expandable TAVR sheaths: which sheath fits which prosthesis?

01 Aug 2022

This toolbox provides interesting information on which expandable sheath fits which prosthesis.

Johannes Blumenstein

Author

Johannes Blumenstein
Expandable TAVR sheaths: which sheath fits which prosthesis?

The importance of hemodynamic performance in transcatheter aortic valves

04 Jul 2022

Watch the 1st of #PCRtokyo 2022’s six live webinars about ‘The importance of hemodynamic performance in transcatheter aortic valves’.

The importance of hemodynamic performance in transcatheter aortic valves

Commissural alignment after balloon-expandable transcatheter aortic valve replacement is associated with improved hemodynamic outcomes

20 Jun 2022

This study aimed at investigating the impact of commissural misalignment on clinical outcomes and hemodynamic performance of balloon-expandable devices.

Alessandro Beneduce

Reviewer

Alessandro Beneduce

Reviewer

Salvatore Brugaletta
Commissural alignment after balloon-expandable transcatheter aortic valve replacement is associated with improved hemodynamic outcomes

Transcatheter aortic valve replacement with self-expanding ACURATE neo2

20 Jun 2022

This study investigated the short-term safety and efficacy of the new valve ACURATE neo2 in comparison to the first neo model in a real-world population.

M. Pighi

Reviewer

Michele Pighi
Mattia Lunardi

Reviewer

Mattia Lunardi
Transcatheter aortic valve replacement with self-expanding ACURATE neo2

Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial

16 Jun 2022

The UK TAVI trial sought to compare TAVI with SAVR in patients with severe, symptomatic aortic stenosis and moderately increased surgical risk.

Daniele Giacoppo

Reviewer

Daniele Giacoppo
Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis: a randomized clinical trial

Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE Neo2

09 Jun 2022

The ACURATE neo2 valve was developed to reduce the risk of paravalvular AR with an increased sealing skirt. This retrospective study aimed to compare TAVI with the ACURATE neo and neo2 devices.

Hennessey

Reviewer

Breda Hennessey
Nicola Ryan

Reviewer

Nicola Ryan
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2

Evolution and prognostic impact of cardiac damage after aortic valve replacement

24 May 2022

The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.

Elad Asher

Reviewer

Elad Asher
Evolution and prognostic impact of cardiac damage after aortic valve replacement

Balloon- versus self-expanding valve systems for treating small failed surgical aortic bioprostheses: the LYTEN trial

23 May 2022

Luigi provides us with the interventional cardiologist's point of view!

Currently, TAVR selection process is performed by matching the internal diameter of the surgically implanted bioprostheses to the external diameter of commercially available TAVR devices. Nonetheless, the impact of intrinsic design differences, such as supra vs intra-annular design,...

Luigi Biasco

Reviewer

Luigi Biasco
Balloon- versus self-expanding valve systems for treating small failed surgical aortic bioprostheses: the LYTEN trial

EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease

22 May 2022

Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!

Jonathan Curio

Author

Jonathan Curio
EuroPCR 2022 - LBT summaries

Late-breaking science overview - What did we learn @EuroPCR 2022?

20 May 2022 – From EuroPCR 2022

Watch this video to gain insight into late-breaking studies and trials presented during EuroPCR 2022:

  • Intravascular imaging vs. angiography-guided PCI in high bleeding risk patients
  • Trancatheter Aortic Valve Repair for aortic insufficiency using the Cusper device
  • Angiography-derived coronary microcirculatory assessment in INOCA patients
  • Blood pressure and MACE reductions after renal...
Late-breaking science overview - What did we learn @EuroPCR 2022?

First dedicated transcatheter leaflet splitting device from bench to first-in-man

20 May 2022 – From EuroPCR 2022

Pierre Deharo interviews Didier Tchétché on the first transcatheter leaflet splitting device (ShortCut device)which can be targeted for bicuspid aortic valves and valve-in-valve procedures.

First dedicated transcatheter leaflet splitting device from bench to first-in-man

Management of a patient with severe CAD and aortic valve stenosis

20 May 2022 – From EuroPCR 2022

Watch the LIVE case of an 87-year-old male patient with a history of hypertension and dyslipidemia but no other significant cardiovascular risk factors and remarkably good health for an elderly man, but with angina for some months and dyspnea, and discuss the management of TAVI candidates with...

Management of a patient with severe CAD and aortic valve stenosis

Our patient with aortic stenosis

20 May 2022 – From EuroPCR 2022

Watch this session to improve your skills in planning TAVI procedure, performing a safe femoral access, and in performing valve implantation

Our patient with aortic stenosis

Predicting and managing TAVI conduction related disorders

20 May 2022 – From EuroPCR 2022

Get key learnings on conduction disorders after TAVI, the role of temporary pacing devices and different strategies to reduce permanent pacemaker implants to the minimum.

Predicting and managing TAVI conduction related disorders

Innovation fireworks

20 May 2022 – From EuroPCR 2022

Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!

Innovation fireworks

Abstract session for nurses and allied professionals

20 May 2022 – From EuroPCR 2022

Among the abstracts presented in this session, discover the impact of sheath size on time to hemostasis after radial interventions, find out more about telephone follow-up after discharge following TAVI, or view the answer to the question: can we avoid routine midazolam to enhance patients' cognition and knowledge?

Abstract session for nurses and allied professionals

What's new in TAVI - a closer look on procedural planning and device selection

19 May 2022 – From EuroPCR 2022

What's new in TAVI -

Streamlined TAVI with Tokyo Live @EuroPCR

19 May 2022 – From EuroPCR 2022

Watch the live case from Milan, Italy, of an 88-year-old female patient with hypertension who was admitted for dyspnoea with discovery of severe aortic stenosis to consider state-of-the-art TAVI.

Streamlined TAVI with Tokyo Live @EuroPCR

Complex heart problems in cancer patients

19 May 2022 – From EuroPCR 2022

TAVI and thrombocytopenia, TAVI, CAD and hepatocarcinoma, or even severe aortic regurgitation and ovarian cancer with infective endocarditis: analyze the case of different cancer patients to be treated for cardiac pathologies in this session from EuroPCR 2022.

Complex heart problems in cancer patients